Surgery Partners, Inc.
SGRYNASDAQHealthcare● Active
$13.86
+$0.15(+1.06%)
Market Cap$1.8B
P/E Ratio—
52W High$24.1
52W Low$11.41
Surgery Partners, Inc.（SGRY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SGRY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.10B | $0.01B | $0.14B | $0.09B | $0.07B |
| Depreciation & Amort. | $0.18B | $0.15B | $0.12B | $0.11B | $0.10B |
| Stock-Based Comp. | $0.01B | $0.03B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.11B) | ($0.12B) | ($0.06B) | ($0.10B) | ($0.15B) |
| Net Cash from Operations | $0.27B | $0.30B | $0.29B | $0.16B | $0.09B |
| Investing Activities | |||||
| Capital Expenditure | ($0.08B) | ($0.09B) | ($0.09B) | ($0.08B) | ($0.06B) |
| Purchases of Investments | ($0.01B) | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.25B) | ($0.49B) | ($0.23B) | ($0.31B) | ($0.33B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.01B) |
| Debt Issued / Repaid | $0.16B | $0.45B | $0.02B | ($0.64B) | ($0.04B) |
| Net Cash from Financing | ($0.06B) | $0.26B | ($0.16B) | $0.04B | $0.32B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.20B | $0.21B | $0.20B | $0.08B | $0.03B |
| FCF Margin %(computed) | 5.91% | 6.73% | 7.47% | 3.08% | 1.33% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Surgery Partners, Inc.
关于Surgery Partners, Inc.（SGRY）现金流量表
Surgery Partners, Inc. 2025财年经营活动现金流$0.27B，自由现金流$0.20B（FCF利润率5.91%），资本支出($0.08B)。
常见问题
SGRY · 4 问Surgery Partners, Inc. 2025财年自由现金流$0.20B，同比down6.7%。
SGRY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10